Metabolomics variation profiling of vaginal discharge identifies potential targets for cervical cancer early warning

Hanjie Xu; Min Liu; Yuexiao Song; Lou Liu; Feng Xu; Jiale Chen; Huiying Zhan; Ye Zhang; Yu Chen; Mudan Lu; Daozhen Chen

doi:10.3724/abbs.2022133

Metabolomics variation profiling of vaginal discharge identifies potential targets for cervical cancer early warning

Acta Biochim Biophys Sin (Shanghai). 2022 Sep 25;54(10):1561-1565. doi: 10.3724/abbs.2022133.

Authors

Hanjie Xu¹, Min Liu¹, Yuexiao Song¹, Lou Liu¹, Feng Xu¹, Jiale Chen¹, Huiying Zhan¹, Ye Zhang¹, Yu Chen², Mudan Lu¹, Daozhen Chen^{1

3}

Affiliations

¹ The Affiliated Wuxi Maternity and Child Health Care Hospital of Nanjing Medical University, Wuxi 214000, China.
² Research Institute for Reproductive Health and Genetic Diseases, the Affiliated Wuxi Maternity and Child Health Care Hospital of Nanjing Medical University, Wuxi 214000, China.
³ Haidong No. 2 People's Hospital, Haidong 810699, China.

No abstract available

MeSH terms

Female
Humans
Metabolomics
Uterine Cervical Neoplasms*
Vaginal Discharge*

Grants and funding

This work was supported by the grants from the Development & Demonstration Program of Wuxi (No. N20192004), the Key Research & Development Program of Jiangsu Province (No. BE2015617), the 5th Phase of “Project 333” of Jiangsu Province of China (No. BRA2019024), Taihu Lake Talent Plan of Wuxi, Innovation and Entrepreneurship Training Program for College Students in Jiangsu Province (No. KYCX19_1182), and Qinghai Province Key Research and Development and Transformation Plan Specific fund of Science and Technology Assistance to Qinghai (No. 2022-QY-216).